ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,978Medicare Part D Prescriptions Filled, Including Refills

Rank: 194 out of 1199

$434K Total Retail Price of All Prescriptions

Rank: 329 out of 1199

376 Patients Receiving at Least One Drug in Part D
54% Patients 65 Years and Older
87% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Virginia
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

11% of this provider’s 376 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

5% of this provider’s 376 patients filled at least one prescription for a schedule three drug, compared to an average of 8%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$43 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Virginia
AMLODIPINE BESYLATE 486 316 75 1 1
LISINOPRIL 447 236 69 2 3
METOPROLOL TARTRATE 347 205 49 3 11
OMEPRAZOLE 325 157 46 4 5
SIMVASTATIN 276 144 37 5 2
NAMENDA 275 270* 21 6 36
FUROSEMIDE 265 197 48 7 7
LEVOTHYROXINE SODIUM 254 202 35 8 4
METFORMIN HCL 239 142 40 9 8
METOPROLOL SUCCINATE 217 153 31 10 16
OXYCODONE-ACETAMINOPHEN 194 111 34 S2 11 66
ATORVASTATIN CALCIUM 193 103 31 12 6
QUETIAPINE FUMARATE 188 143 27 A 13 45
DONEPEZIL HCL 186 173 33 14 30
LORAZEPAM 134 110 23 B 15 26
LEVETIRACETAM 131 90 20 16 83
WARFARIN SODIUM 127 81 16 17 14
OXYBUTYNIN CHLORIDE ER 125 71 24 18 144
PANTOPRAZOLE SODIUM 122 81 26 19 24
FAMOTIDINE* 119 71 20 20 74
CIPROFLOXACIN HCL 117 53 75 21 69
HYDROCHLOROTHIAZIDE 115 69 20 22 10
CLOPIDOGREL 94 89* 15 23 20
MIRTAZAPINE 89 84* 18 24 52
CITALOPRAM HBR 87 76 15 25 25
NAPROXEN 86 36 19 26 113
GABAPENTIN 84 36 22 27 15
BENZTROPINE MESYLATE 79 42 14 R 28 158
OXYBUTYNIN CHLORIDE 79 19 13 28 160
KLOR-CON M20 78 50 14 30 48
CARVEDILOL 72 52 16 31 22
CLONIDINE HCL 71 <11 <11 32 51
ATENOLOL 70 <11 <11 33 17
TRAMADOL HCL 65 43 23 34 18
DIVALPROEX SODIUM 65 <11 <11 34 108
HUMALOG 62 44 15 36 96
LANTUS 61 25 17 37 60
IBUPROFEN 60 <11 24 38 78
CARBIDOPA-LEVODOPA 60 <11 <11 38 135
BACLOFEN 60 <11 <11 38 98
RISPERIDONE 59 42 15 A 41 75
PHENYTOIN SODIUM EXTENDED 58 <11 <11 42 148
POTASSIUM CHLORIDE 58 53* 13 42 19
ADVAIR DISKUS 56 29 18 44 59
HALOPERIDOL 54 19 19 A 45 179
OLANZAPINE 53 <11 <11 A 46 137
GLIPIZIDE 50 <11 <11 47 50
DIAZEPAM 50 <11 <11 B 47 82
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 28, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.